StockData

Alpha Cognition vs Scilex

ACOG and SCLX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ACOG and SCLX compare

Alpha Cognition is the larger company, worth 14 times as much as Scilex ($171M against $12.1M).

Alpha Cognition keeps more of each dollar of sales as profit, with a net margin of −154% compared with −1470% at Scilex.

Alpha Cognition scores higher on the StockData Score (7 against 1 for Scilex), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricACOGSCLX
Size and price
Market cap$171M$12.1M
Share price$7.83$1.43
Change, 1 year27.7%−92.4%
Change, 5 years−63.2%−99.6%
Beta (5Y)2.49–
Employees7234
StockData Score
Total score7 (better)1
Valuation score01 (better)
Growth score00
Performance score1 (better)0
Health score6 (better)0
Dividend score00
Valuation
P/S11.2×0.4× (better)
P/B3.2×–
FCF yield−18.3%–
Fair value$4.89–
Margin of safety−60.2%–
Growth
Revenue growth (TTM)–−28.5%
Revenue growth, 5Y average–5.1%
Profitability
Gross margin92.7%161% (better)
Operating margin−191% (better)−1136%
Net margin−154% (better)−1470%
FCF margin−204%–
Return on equity−58.8%–
Financial health
Debt / equity0.00–
Interest coverage–−22.2×
Current ratio9.03 (better)0.07
Altman Z-score6.12 (better)−12.74
Piotroski F-score34 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions48.7%9.8%
Held by insiders5.1%–
Insider net buying, 12 months$8.3M (better)−$12.8M
Short interest, % of float2.0%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.